project id: TCGA-CESC; case submitter id: TCGA-DS-A0VL; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.2; spectrophotometer method: UV Spec; age at index: 25; days to birth: -9186; days to death: 1692; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1976; age at diagnosis: 9186; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic t: T1b1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 81.0; figo stage: Stage IB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2001; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3243; initial weight: 120.0; sample id: cdf4ab19-f243-4efc-a5dc-8253cbe48845; sample submitter id: TCGA-DS-A0VL-01A; portion id: 0570d958-fdc4-4381-9abc-7493712be245; portion submitter id: TCGA-DS-A0VL-01A-21; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;